Biochemistry (Washington) 2001-01-23

Direct inhibition of the hexose transporter GLUT1 by tyrosine kinase inhibitors.

J C Vera, A M Reyes, F V Velásquez, C I Rivas, R H Zhang, P Strobel, J C Slebe, J Núñez-Alarcón, D W Golde

文献索引:Biochemistry 40(3) , 777-90, (2001)

全文:HTML全文

摘要

The facilitative hexose transporter GLUT1 is a multifunctional protein that transports hexoses and dehydroascorbic acid, the oxidized form of vitamin C, and interacts with several molecules structurally unrelated to the transported substrates. Here we analyzed in detail the interaction of GLUT1 with a group of tyrosine kinase inhibitors that include natural products of the family of flavones and isoflavones and synthetic compounds such as the tyrphostins. These compounds inhibited, in a dose-dependent manner, the transport of hexoses and dehydroascorbic acid in human myeloid HL-60 cells, in transfected Chinese hamster ovary cells overexpressing GLUT1, and in normal human erythrocytes, and blocked the glucose-displaceable binding of cytochalasin B to GLUT1 in erythrocyte ghosts. Kinetic analysis of transport data indicated that only tyrosine kinase inhibitors with specificity for ATP binding sites inhibited the transport activity of GLUT1 in a competitive manner. In contrast, those inhibitors that are competitive with tyrosine but not with ATP failed to inhibit hexose uptake or did so in a noncompetitive manner. These results, together with recent evidence demonstrating that GLUT1 is a nucleotide binding protein, support the concept that the inhibitory effect on transport is related to the direct interaction of the inhibitors with GLUT1. We conclude that predicted nucleotide-binding motifs present in GLUT1 are important for the interaction of the tyrosine kinase inhibitors with the transporter and may participate directly in the binding transport of substrates by GLUT1.


相关化合物

  • 2,5-二羟基肉桂酸甲...

相关文献:

Mechanism of topoisomerase II inhibition by staurosporine and other protein kinase inhibitors.

1996-10-18

[J. Biol. Chem. 271(42) , 26418-23, (1996)]

Signal pathways that transduce growth factor-stimulated mitogenesis in bone cells.

1998-07-01

[Bone 23(1) , 17-26, (1998)]

Suppression of tyrosine kinase activity inhibits [3H]thymidine uptake in cultured human pituitary tumor cells.

1997-07-01

[J. Clin. Endocrinol. Metab. 82(7) , 2143-7, (1997)]

Regulation of the renal Na-HCO3 cotransporter: IX. Modulation by insulin, epidermal growth factor and carbachol.

1998-10-16

[Regul. Pept. 77(1-3) , 155-61, (1998)]

Tyrosine kinase inhibitor, methyl 2,5-dihydromethylcinnimate, induces PML nuclear body formation and apoptosis in tumor cells.

2007-08-01

[Exp. Cell Res. 313(13) , 2753-65, (2007)]

更多文献...